menu
    • menu

    Company profile for Aktis Oncology

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital with its seasoned team of entrepreneurs and drug developers, Aktis has developed proprietary platforms to generate tumor targeting agents with ideal properties for radiotherapy. Designed for high tumor penetration a...
    Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital with its seasoned team of entrepreneurs and drug developers, Aktis has developed proprietary platforms to generate tumor targeting agents with ideal properties for radiotherapy. Designed for high tumor penetration and long residence time, Aktis Oncology’s molecules can quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing side effects of treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aktis OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    17 Drydock Avenue, Suite #17-401, Boston, MA 02210
    Telephone
    Telephone
    202.930.4762
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aktisoncology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aktis Oncology Appoints Kyle Kuvalanka as Chief Financial Officer
    Aktis Oncology Appoints Kyle Kuvalanka as Chief Financial Officer

    05 Nov 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/aktis-oncology-appoints-kyle-kuvalanka-chief-financial-officer/

    CONTRACTPHARMA
    05 Nov 2025
    Share Share
    Aktis Oncology Appoints Industry Veteran Mike Sherman to Board
    Aktis Oncology Appoints Industry Veteran Mike Sherman to Board

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aktis-oncology-appoints-accomplished-life-sciences-industry-veteran-mike-sherman-to-its-board-of-directors-302523746.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    Aktis Starts Ph1b Trial Of Nectin-4 Radiopharma AKY-1189
    Aktis Starts Ph1b Trial Of Nectin-4 Radiopharma AKY-1189

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aktis-oncology-initiates-phase-1b-clinical-trial-of-its-nectin-4-targeting-radiopharmaceutical-product-candidate-aky-1189-across-multiple-tumor-types-302466453.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    Aktis Oncology Appoints Mary Thistle to its Board of Directors
    Aktis Oncology Appoints Mary Thistle to its Board of Directors

    04 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aktis-oncology-appoints-biotech-industry-veteran-mary-thistle-to-its-board-of-directors-302367171.html

    PR NEWSWIRE
    04 Feb 2025
    Share Share
    Aktis Presents First Clinical Data For AKY-1189 At Symposium
    Aktis Presents First Clinical Data For AKY-1189 At Symposium

    24 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aktis-oncology-announces-presentation-of-the-first-clinical-data-supporting-broad-development-of-a-first-in-class-nectin-4-targeting-radiopharmaceutical-aky-1189-at-2024-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-the-302286329.html

    PR NEWSWIRE
    24 Oct 2024
    Share Share
    Lilly-partnered radiopharma startup Aktis Oncology raises $175M
    Lilly-partnered radiopharma startup Aktis Oncology raises $175M

    01 Oct 2024

    // Delilah Alvarado BIOPHARMADIVE

    https://www.biopharmadive.com/news/aktis-series-b-radiopharmaceutical-cancer-ra-capital-funding/728419/

    Delilah Alvarado BIOPHARMADIVE
    01 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search